Repository Corticotropin recalls
The FDA has published 2 recalls involving Repository Corticotropin since 2024. The latest was reported on 2 Sep 2026. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2024
Last 12 months1reported
Class I00% of total
Ongoing2latest 2 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why repository corticotropin is recalled
Companies
By year
Ongoing repository corticotropin recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Acthar Gel (repository corticotropin injection) multiple-dose vial recalledActhar | Mallinckrodt Hospital Products | Particulate Matter | Nationwide |
| Drug | CLASS II | Acthar Gel (repository corticotropin injection) recalledActhar | Mallinckrodt Hospital Products | Manufacturing (CGMP) Deviations | Nationwide |
All repository corticotropin recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Acthar Gel (repository corticotropin injection) multiple-dose vial recalledActhar | Mallinckrodt Hospital Products | Particulate Matter | Nationwide |
| Drug | CLASS II | Acthar Gel (repository corticotropin injection) recalledActhar | Mallinckrodt Hospital Products | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Repository Corticotropin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.